ETON PHARMACEUTICALS INC (ETON) Stock Analyst Earnings Estimates
NASDAQ:ETON - Nasdaq - US29772L1089 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 21.25M -2.66% | 31.642M 48.90% | 39.011M 23.29% | 78.458M 101.12% | 114.32M 45.71% | 159.85M 39.83% | 203.04M 27.02% | 237.73M 17.09% | 269.55M 13.38% | 398.09M 47.69% | 445.36M 11.87% | |
| EBITDA YoY % growth | -6.98M -571.15% | -291K 95.83% | -1.036M -256.01% | 20.094M 2,039.58% | 41.208M 105.08% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -8.75M -483.33% | -1.192M 86.38% | -2.182M -83.05% | 10.276M 570.94% | 38.057M 270.35% | 69.042M 81.42% | 100.78M 45.97% | 123.87M 22.91% | 145.22M 17.24% | 242.03M 66.66% | 276.95M 14.43% | |
| Operating Margin | -41.18% | -3.77% | -5.59% | 13.10% | 33.29% | 43.19% | 49.64% | 52.11% | 53.87% | 60.80% | 62.19% | |
| EPS YoY % growth | -0.35 -218.18% | -0.06 82.86% | -0.14 -133.33% | 0.28 301.57% | 1.31 362.65% | 1.94 48.83% | 2.73 40.42% | 3.31 21.31% | 3.85 16.18% | 5.70 48.28% | 6.52 14.31% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.10 217.32% | 0.24 1,289.98% | 0.22 220.57% | 0.30 395.80% | 0.34 253.58% | 0.38 58.57% |
| Revenue Q2Q % growth | 20.883M 102.28% | 22.257M 91.10% | 25.347M 46.67% | 24.888M 31.49% | 26.418M 26.50% | 27.744M 24.65% |
| EBITDA Q2Q % growth | 6.222M 378.62% | 7.548M 244.66% | 7.736M 1,324.68% | 9.234M 185.26% | 10.144M 63.03% | 11.389M 50.89% |
| EBIT Q2Q % growth | 3.437M 575.25% | 6.756M 547.13% | 5.508M 1,271.91% | 8.976M 1,367.41% | 9.894M 187.87% | 11.118M 64.56% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.10 16.67% | -0.04 | -0.06 | -167.36% |
| Q1 2025 Q2Q % growth | 0.07 333.33% | 0.05 | 0.02 | 28.68% |
| Q4 2024 Q2Q % growth | -0.02 77.78% | 0.00 | -0.02 | -488.82% |
| Q3 2024 Q2Q % growth | 0.03 250.00% | -0.01 | 0.04 | 394.12% |
| Q2 2024 Q2Q % growth | -0.12 -180.00% | -0.07 | -0.05 | -68.07% |
| Q1 2024 Q2Q % growth | -0.03 70.00% | -0.05 | 0.02 | 34.64% |
| Q4 2023 Q2Q % growth | -0.09 -325.00% | -0.04 | -0.05 | -120.59% |
| Q3 2023 Q2Q % growth | -0.02 83.33% | -0.10 | 0.08 | 80.39% |
| Q2 2023 Q2Q % growth | 0.15 350.00% | -0.09 | 0.24 | 263.40% |
| Q1 2023 Q2Q % growth | -0.10 52.38% | -0.14 | 0.04 | 29.97% |
| Q4 2022 Q2Q % growth | 0.04 | 0.01 | 0.03 | 292.16% |
| Q3 2022 Q2Q % growth | -0.12 50.00% | -0.15 | 0.03 | 21.57% |
| Q2 2022 Q2Q % growth | -0.06 40.00% | 0.03 | -0.09 | -296.08% |
| Q1 2022 Q2Q % growth | -0.21 -210.53% | -0.08 | -0.13 | -157.35% |
| Q4 2021 Q2Q % growth | 0.04 112.50% | 0.19 | -0.15 | -79.36% |
| Q3 2021 Q2Q % growth | -0.24 22.58% | -0.14 | -0.10 | -74.29% |
| Q2 2021 Q2Q % growth | -0.10 56.52% | -0.14 | 0.04 | 29.97% |
| Q1 2021 Q2Q % growth | 0.19 138.00% | 0.19 | 0.00 | -1.96% |
| Q4 2020 Q2Q % growth | -0.32 -113.33% | -0.27 | -0.05 | -20.66% |
| Q3 2020 Q2Q % growth | -0.31 -10.71% | -0.26 | -0.05 | -19.97% |
| Q2 2020 Q2Q % growth | -0.23 -27.78% | -0.27 | 0.04 | 13.27% |
| Q1 2020 Q2Q % growth | -0.50 | -0.23 | -0.27 | -119.49% |
| Q4 2019 Q2Q % growth | -0.15 | -0.27 | 0.12 | 44.15% |
| Q3 2019 Q2Q % growth | -0.28 | -0.25 | -0.03 | -11.29% |
| Q2 2019 Q2Q % growth | -0.18 | -0.28 | 0.10 | 35.83% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 18.928M 108.60% | 17.046M | 1.882M | 11.04% |
| Q1 2025 Q2Q % growth | 17.282M 116.95% | 15.434M | 1.848M | 11.97% |
| Q4 2024 Q2Q % growth | 11.647M 59.26% | 10.741M | 906K | 8.43% |
| Q3 2024 Q2Q % growth | 10.324M 46.90% | 9.889M | 435K | 4.40% |
| Q2 2024 Q2Q % growth | 9.074M -24.36% | 8.976M | 98K | 1.09% |
| Q1 2024 Q2Q % growth | 7.966M 50.19% | 8.16M | -194K | -2.38% |
| Q4 2023 Q2Q % growth | 7.313M -13.96% | 7.854M | -541K | -6.89% |
| Q3 2023 Q2Q % growth | 7.028M 118.26% | 6.384M | 644K | 10.09% |
| Q2 2023 Q2Q % growth | 11.997M 63.00% | 6.639M | 5.358M | 80.70% |
| Q1 2023 Q2Q % growth | 5.304M 143.30% | 4.647M | 657K | 14.14% |
| Q4 2022 Q2Q % growth | 8.5M 39.57% | 9.301M | -801K | -8.61% |
| Q3 2022 Q2Q % growth | 3.22M 312.82% | 3.11M | 110K | 3.54% |
| Q2 2022 Q2Q % growth | 7.36M 139.74% | 7.92M | -560K | -7.07% |
| Q1 2022 Q2Q % growth | 2.18M -81.68% | 7.242M | -5.062M | -69.90% |
| Q4 2021 Q2Q % growth | 6.09M 7,512.50% | 12.768M | -6.678M | -52.30% |
| Q3 2021 Q2Q % growth | 780K 587.50% | 3.102M | -2.322M | -74.85% |
| Q2 2021 Q2Q % growth | 3.07M 15,250.00% | 3.887M | -817K | -21.02% |
| Q1 2021 Q2Q % growth | 11.9M 11,800.00% | 12.295M | -395K | -3.21% |
| Q4 2020 Q2Q % growth | 80K -82.61% | 1.361M | -1.281M | -94.12% |
| Q3 2020 Q2Q % growth | -160K | 1.519M | -1.679M | -110.53% |
| Q2 2020 Q2Q % growth | 20K | 300.217K | -280.217K | -93.34% |
| Q1 2020 Q2Q % growth | 100K -80.00% | 1.545M | -1.445M | -93.53% |
| Q4 2019 Q2Q % growth | 460K | 683.737K | -223.737K | -32.72% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 31.24% | -157.9% | 0% | -30.83% |
| Revenue | 0.69% | -1.29% | -1.32% | 4.57% |